Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

MRI in Neuromuscular Diseases: An Emerging Diagnostic Tool and Biomarker for Prognosis and Efficacy

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. A New Glycogen Storage Disease Caused by a Dominant PYGM Mutation

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Neurophysiological signatures of motor impairment in patients with Rett syndrome

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Neuroinflammatory markers associate with cognitive decline after major surgery: findings of an explorative study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Hypersensitivity to Calcitonin Gene-Related Peptide in Post-Traumatic Headache

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Data from the European registry for patients with McArdle disease and other muscle glycogenoses (EUROMAC)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Vacuoles, Often Containing Glycogen, Are a Consistent Finding in Hypokalemic Periodic Paralysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Editorial: Remaining diagnostic issues and start of a treatment era for muscle diseases

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

There is an unmet need to identify biomarkers sensitive to change in rare, slowly progressive neuromuscular diseases. Quantitative magnetic resonance imaging (MRI) of muscle may offer this opportunity, as it is noninvasive and can be carried out almost independent of patient cooperation and disease severity. Muscle fat content correlates with muscle function in neuromuscular diseases, and changes in fat content precede changes in function, which suggests that muscle MRI is a strong biomarker candidate to predict prognosis and treatment efficacy. In this paper, we review the evidence suggesting that muscle MRI may be an important biomarker for diagnosis and to monitor change in disease severity. ANN NEUROL 2020;88:669-681.

OriginalsprogEngelsk
TidsskriftAnnals of Neurology
Vol/bind88
Udgave nummer4
Sider (fra-til)669-681
Antal sider13
ISSN0364-5134
DOI
StatusUdgivet - okt. 2020

Bibliografisk note

© 2020 American Neurological Association.

ID: 61073243